NovoCure Limited (NVCR)
18.88
-0.09 (-0.47%)
At close: Mar 28, 2025, 3:59 PM
18.77
-0.58%
After-hours: Mar 28, 2025, 07:47 PM EDT
NovoCure Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 163.77M | 240.82M | 115.33M | 208.8M | 234.67M | 177.32M | 140.62M | 78.59M | 99.78M | 119.42M | 57.61M | 175.89M |
| Short-Term Investments | 796.11M | 669.79M | 854.1M | 728.9M | 607.9M | 148.77M | 105.26M | 104.72M | 119.85M | 150M | 45M | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 14.62M | 14.02M | 11.16M | 12.09M | 10.91M | 4.9M | 3.06M | 2.1M | 1.59M | 851K | 297K | 252K |
| Receivables | 102.07M | 77.11M | 86.26M | 93.57M | 96.7M | 58.86M | 36.52M | 29.57M | 6.34M | n/a | n/a | n/a |
| Inventory | 35.09M | 38.15M | 29.38M | 24.43M | 27.42M | 23.7M | 22.55M | 22.02M | 25.55M | 13.59M | 3.45M | 1.89M |
| Other Current Assets | 9.54M | 8.53M | 26.47M | 17.83M | 32.74M | 31.3M | 5.67M | 5.02M | 2.5M | 10.89M | 5.77M | 5.7M |
| Total Current Assets | 1.11B | 1.03B | 1.11B | 1.07B | 999.44M | 439.95M | 321.37M | 245.13M | 261.87M | 293.9M | 111.83M | 183.48M |
| Property-Plant & Equipment | 119.59M | 97.7M | 68.96M | 53.88M | 41.63M | 34.6M | 15.37M | 18.07M | 18.62M | 12.58M | 5.75M | 5.18M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 134.21M | 111.72M | 80.12M | 65.97M | 52.54M | 39.5M | 18.42M | 20.16M | 20.21M | 13.43M | 6.05M | 5.43M |
| Total Assets | 1.24B | 1.15B | 1.19B | 1.14B | 1.05B | 479.45M | 339.79M | 265.3M | 282.08M | 307.34M | 117.88M | 188.91M |
| Account Payables | 105.09M | 94.39M | 85.2M | 72.6M | 53.65M | 36.92M | 26.71M | 17.21M | 18.36M | 13.9M | 10.03M | 10.29M |
| Deferred Revenue | 14.22M | 16.22M | 18.03M | 17.76M | 17.77M | 11.77M | 8.84M | 4.96M | 2.27M | n/a | n/a | n/a |
| Short-Term Debt | 101.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 536.01M | 59.37M | 46.89M | 46.44M | 36.86M | 25.6M | 16.75M | 18.93M | 13.12M | 11.87M | 6.94M | 4.93M |
| Total Current Liabilities | 756.38M | 179.12M | 158.78M | 142.6M | 113.61M | 86.31M | 64.56M | 50.2M | 36.88M | 28.63M | 17.67M | 15.6M |
| Long-Term Debt | n/a | 596.24M | 584.27M | 575.21M | 444.2M | 163.56M | 149.27M | 97.34M | 96.23M | 23.1M | 321K | 346K |
| Other Long-Term Liabilities | 124.23M | 8.28M | 4.55M | 4.71M | 5.51M | 3.98M | 3.65M | 4.19M | 6.62M | 4.79M | 2.01M | 1.19M |
| Total Long-Term Liabilities | 124.23M | 604.52M | 591.7M | 586.4M | 461.85M | 175.35M | 162.97M | 101.53M | 102.85M | 27.89M | 2.33M | 1.53M |
| Total Liabilities | 880.61M | 783.63M | 750.48M | 729M | 575.46M | 261.66M | 227.53M | 151.73M | 139.74M | 56.52M | 20M | 17.13M |
| Total Debt | 93.13M | 596.24M | 584.27M | 575.21M | 444.2M | 163.56M | 149.27M | 97.34M | 96.23M | 23.1M | 321K | 346K |
| Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -1.15B | -985.5M | -778.46M | -685.93M | -631.08M | -650.88M | -643.65M | -582.26M | -519.93M | -388.08M | -276.5M | -195.82M |
| Comprehensive Income | -5.5M | -5.47M | -2.43M | -3.17M | -3.83M | -2.77M | -1.4M | -1.34M | -1.88M | -1.5M | -4.28M | -2.41M |
| Shareholders Equity | 360.18M | 362.5M | 441.17M | 410.49M | 476.53M | 217.79M | 112.26M | 113.56M | 142.34M | 250.82M | 97.88M | 171.78M |
| Total Investments | 796.11M | 669.79M | 854.1M | 728.9M | 607.9M | 148.77M | 105.26M | 104.72M | 119.85M | 150M | 45M | n/a |